Myocarditis is an inflammatory condition mainly located in the myocardium. Its incidence and mortality in the Japanese population have not been determined, since definitive diagnosis of myocarditis is difficult. These "Guidelines for Diagnosis and Treatment of Myocarditis" have been compiled based on basic and clinical research on myocarditis which has been conducted using sound scientific methods in Japan, though the evidence obtained may not qualify as that of evidencebased medicine. In the guidelines, cardiac magnetic resonance (CMR) imaging is considered valuable as an effective means of diagnosis of myocarditis. In addition, information on cardiac sarcoidosis, autoimmune myocarditis, and drug-induced myocarditis is included.
Blood Biochemistry
Myocarditis is confirmed by the findings of transient elevation of C-reactive protein (CRP), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), the MB form creatine kinase (CK-MB), and cardiac troponin T in blood. 6 Troponin T, which can be measured quickly and easily in whole blood by enzyme-linked immunosorbent assay (ELISA), is especially useful for immediate diagnosis. However, which type of troponin, T or I, in more useful for diagnosis has not been determined. 7 4 Chest X-Ray A chest X-ray is useful for visualizing cardiac enlargement and pulmonary congestion.
Electrocardiography (ECG)
The ECG is a sensitive and convenient means of diagnosis of myocarditis. It must be timely repeated, since minor abnormalities in the ECG detected initially may become clearer over time. Abnormal ST-T waves and conduction block are frequently observed in myocarditis. A gradual increase in the width of the QRS complex is a sign of exacerbation of myocarditis. Continuous ECG monitoring is crucial to detect potentially fatal arrhythmias.
Echocardiography
Myocarditis can be confirmed by transient wall thickening, reduced wall motion and reduced cardiac chamber size in addition to pericardial effusion on echocardiography. 8 Echocardiography is especially useful for pediatric patients.
Cardiac Magnetic Resonance (CMR)
In addition to the cinematic mode on magnetic resonance imaging (MRI), T1-weighted early signal enhancement and gadolinium-delayed imaging of the heart are useful to make a positive diagnosis of myocarditis. 9-11 T2-weighted images reveal the regions of the heart affected by inflammation. CMR imaging can differentiate acute myocarditis from acute myocardial infarction; acute myocarditis exhibits erosive or spotty areas in the epicardium, while lesions of acute myocardial infarction spread from the endocardium like a wave front.
Nuclear Medicine Techniques
In gallium-67 ( 67 Ga) myocardial imaging, 67 Ga uptake in the myocardium is highly specific for detection of myocarditis, though this method is not highly sensitive. 12 On the other hand, technetium-99m ( 99m Tc) pyrophosphate myocardial scintigraphy has relatively high sensitivity but is not specific. 13 
Cardiac Catheterization Including Endomyocardial Biopsy
Cardiac catheterization may be performed in the acute phase of myocarditis if the patient's condition allows. After coronary lesion has been excluded, an endomyocardial biopsy should be performed to detect myocardial degeneration, myocyte necrosis, inflammatory infiltrates, and/or interstitial edema of the myocardium. Even if the results are negative, the presence of myocarditis cannot be excluded due to the possibility of sampling errors. 14 Biopsy sampling at three or more different sites is therefore strongly recommended. 15 
Diagnosis of Viral Infection
Viral infection is confirmed if the viral antibody titer is at least four times higher in an acute phase serum sample than in a sample obtained in remission phase collected at least two weeks apart. However, only approximately 10% of patients with viral infection exhibit a positive antibody titer. Polymerase chain reaction (PCR) is more useful for identifying the genomes of viruses causing myocarditis, but is not commonly performed. 16 
Methods of Diagnosis and Evaluation
Clinical diagnosis of myocarditis should be performed following the "Diagnostic guidelines for acute myocarditis" 17 ( Table 2) . 
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If acute myocardial infarction is excluded but active lesions of myocarditis can be confirmed on endomyocardial biopsy 18 (Table 3) , myocarditis is considered definitively diagnosed.
Treatment
The primary signs and symptoms and disease progression of myocarditis are relatively easy to grasp. The inflammatory phase lasts one to two weeks, and is followed by a recovery phase. Myocarditis causes myocardial necrosis and inflammation, which result in cardiac dysfunction and failure. Myocarditis is therefore treated in three ways: (1) intervention to eliminate the cause, (2) intervention to improve hemodynamic compromise, and (3) intervention in cardiac dysfunction (Figure 1 ).
Treatment of Asymptomatic or Mildly Symptomatic Myocarditis
Patients with asymptomatic or mildly symptomatic myocarditis with cardiac signs and symptoms should be admitted to the hospital, kept at bed rest, and monitored carefully. A regimen for cardiopulmonary emergency must be prepared beforehand, in the event of acute changes.
Treatment of Arrhythmia
Patients with arrhythmia caused by severe heart block should temporarily be treated with external pacing. However, use of drugs must be avoided in case of frequent premature beats and nonsustained in patients with ventricular tachycardia.
Management of Heart Failure
For patients with cardiac pump failure in the acute phase, use of catecholamines or carperitide is recommended. If the patient does not respond to treatment, a circulatory assist device should be used.
Additional Treatment for Refractory Myocarditis
In patients with persistent inflammation without signs of hemodynamic improvement, short-term treatment with large doses of corticosteroids may be attempted. 19 There are cases of 4. Localized or diffuse wall thickening, reduced wall motion, reduced cardiac chamber size, and pericardial effusion are found on echocardiography.
5. In myocarditis, myocardial constitutive proteins (cardiac troponin T and creatine kinase-MB) are detected in serum. C-reactive protein and white blood cell count are elevated. Early detection of troponin T using whole blood enables immediate diagnosis of myocarditis.
6. Since the conditions in items 2 and 5 above may progress within a few hours, changes over time in these conditions should be followed. If a patient has bradycardia, widened QRS complex, frequent premature beats, wall thickening, exacerbation of reduced wall motion, elevated troponin T, and continuous increase in troponin T level, the patient may have a cardiopulmonary emergency.
7. Definitive diagnosis of myocarditis requires that acute myocardial infarction be excluded.
8. The presence of abnormal histological findings on endomyocardial biopsy d) makes the diagnosis of myocarditis definite. However, the absence of such findings does not exclude the possibility of myocarditis.
9. Elevation of viral titer in a sample collected in the acute phase to at least four times that in a sample obtained in remission is useful for identify viral infection as the cause. Polymerase chain reaction is often used to demonstrate the presence of viral infection and to detect the viral genome. Separation of virus or identification of virus by antibody titer in throat swabs, urine, feces, blood, and especially pericardial effusion or cardiac muscle tissue provides direct evidence of myocarditis.
a) Flu-like symptoms: Fever, headache, cough, and throat pain. b)
Gastrointestinal symptoms: Nausea, vomiting, stomach ache, and diarrhea. c) Cardiac symptoms: Chest pain, syncope, dyspnea, palpitations, shock, seizure, and cyanosis. d) See Table 3 
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Use PCPS In case 1, IABP is concurrently used 
Considerations in device removal
Consider device removal if assisted volume is reduced up to 1.5 L/min; parameters for circulatory failure: SVO 2 >60% , TB <3.0 mg/dL, LA normal, no acidosis found on arterial blood gas analysis, no exacerbation of organ dysfunction on biochemical tests, stable urine volume, and parameters for cardiac function: improved wall motion, ejection time >200 msec, ETCO 2 PaCO 2 and CCl >2.0 L/min/m 2 are observed.
Device removal Remove the device immediately if no exacerbation of circulatory failure or parameters of cardiac function is observed after assisted volume is reduced to 1.0 L/min. 
CPR is not successful
Electrical defibrillation (3 to 5 times) for ventricular tachycardia and ventricular fibrillation is
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remarkable recovery. Treatment with high dose immunoglobulin may also be considered. 20
Management of Myocarditis in the Recovery Phase
Treatment with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers can be performed to protect the myocardium.
Prognosis and Natural History
In the acute phase, myocarditis management of cardiac pump failure and potentially fatal arrhythmias is the main clinical challenge. The prognosis of myocarditis varies depending on the pathogenesis and type of disease. 21 
II Diagnosis and
Treatment of Specific Types of Myocarditis 1. Fulminant Myocarditis 1 Background Fulminant myocarditis causes acute hemodynamic compromise which may prove fatal. External circulatory support is required to save the patient's life.
Diagnosis
The initial evidence of fulminant myocarditis is very similar to that of acute myocarditis, with cardiac shock and circulatory failure as the main crucial points to be handled. On blood chemistry test, blood cardiac troponin is of chief importance for diagnosis. 22 A continuous decrease in the cardiac troponin level suggests that the patient is stabilizing. Changes over time in the ECG are important, since widening of the QRS complex and frequent ventricular arrhythmia indicate that myocarditis is following a fulminant course. 23 Patients with fulminant myocarditis often have a reduced left ventricular ejection fraction. Monitoring of progressive concentric wall thickening and reduction of wall motion in echocardiography over time is important. 8 Fulminant myocarditis can not be identified by histology. Hemodynamics must be continuously evaluated always with echocardiography and guided often by Swan-Ganz catheterization in serious cases.
Treatment
Management of acute fulminant myocarditis should focus on prevention of hemodynamic which have been compromised and bridging the patient to natural recovery. 24 Intra-aortic balloon pump (IABP), percutaneous cardiopulmonary support (PCPS), and left ventricular assist device (LVAD) are available as circulatory assistance. Circulatory support should be performed for potentially fatal arrhythmias and low cardiac output. When such devices are used, the following are of great importance: (1) selection of device and timing of introduction, (2) assist volume setting, and (3) prevention of complications 4 (Figure 2) . In patients refractory to such support, treatment with immunosuppressant may be acceptable. When cardiac dysfunction or heart block does not improve within 3 to 4 days after the initial signs and symptoms of fulminant myocarditis, brief treatment with high-dose corticosteroids or high-dose immunoglobulin may be considered.
Giant Cell Myocarditis

Background
The clinical presentation of giant cell myocarditis tends to be similar to that of fulminant myocarditis. 25 Allergy and/or autoimmune factors are thought to be involved in giant cell myocarditis.
Table 4. Diagnostic Guidelines for Eosinophilic Myocarditis
If the five minimally required conditions listed below are observed in a patient, eosinophilic myocarditis should be strongly suspected. However, acute myocardial infarction must be excluded by coronary angiography. The diagnosis of eosinophilic myocarditis must be confirmed by endomyocardial biopsy. 
Minimally required conditions
Useful information
1)
Approximately one-third of patients with eosinophilic myocarditis have allergic conditions (such as bronchial asthma, rhinitis and urticaria).
2) Approximately two-thirds of patients with eosinophilic myocarditis have previous flu-like symptoms (such as fever, sore throat and cough).
Endomyocardial biopsy
Histological findings in eosinophilic myocarditis include eosinophil infiltrates, degranulation of eosinophils, disappearance and fusion of cardiomyocytes, and interstitial edema and fibrosis. Occasionally, endocarditis is observed. a) Some patients have an increased eosinophil count in peripheral blood before cardiac symptoms appear, and some patients have cardiac symptoms with a normal eosinophil count, which gradually increases to above 500 /mm 3 . In the acute phase, the eosinophil count must be determined every 2 to 3 days. However, the eosinophil count increases in a different way in each patient. b) ST elevation is observed in approximately 50% and abnormal Q waves are observed in approximately one-third of patients with eosinophilic myocarditis. Atrioventricular block, which occurs in viral myocarditis and idiopathic myocarditis, only rarely occurs in eosinophilic myocarditis. c) Left ventricular wall thickening frequently occurs in eosinophilic myocarditis. Its severity varies among patients. Since wall thickening normalizes within 7 to 14 days, the patient must be monitored over time. ECG, electrocardiography.
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Diagnosis
Multinucleated giant cells can be recognized in inflammatory lesions in the myocardium. Differentiation from cardiac sarcoidosis is of crucial importance. 26 
Treatment
Although there are reports suggesting that corticosteroids and immunosuppressant may be useful for treatment of giant cell myocarditis, the prognosis of giant cell myocarditis is not favorable. 27 
Eosinophilic Myocarditis
Background
Eosinophilic myocarditis is caused by cytotoxic substances such as eosinophilic cationic protein contained in the granules of eosinophils, which infiltrate into the myocardium. Its etiology varies, and includes allergic conditions, drug hypersensitivity, and parasite infection, though it is usually idiopathic. 28 
Diagnosis (Table 4)
Eosinophilic myocarditis is diagnosed based on increased eosinophil counts in peripheral blood and significantly increased eosinophil infiltrates, as well as degranulation and degeneration of cardiomyocytes on biopsy. The timing of the onset of increased eosinophil counts in peripheral blood differs among patients. 29 
Treatment
Patients with mild eosinophilic myocarditis recover naturally. If the patient has heart failure or serious arrhythmia, corticosteroid treatment is necessary. 30 To prevent cardiac wall thrombi, anticoagulants are used. The prognosis is favorable.
Chronic Myocarditis
Background
The concept of chronic myocarditis has not been agreed upon between in Japan and outside of Japan. 3 There are reports suggesting the involvement of viral infection or autoimmunity in chronic myocarditis, though the cause of this condition has not been clearly determined.
Diagnosis
The diagnosis of chronic myocarditis is difficult. It begins in a latent fashion, but then becomes chronic. 3 Acute myocarditis rarely becomes chronic. The symptoms and signs of chronic myocarditis are non-specific and similar to those of dilated cardiomyopathy. Histological findings are characterized by mononuclear cell infiltrates, aggregated interstitial fibrosis, and fatty infiltration. 67 Ga or 99m Tc pyrophosphate myocardial scintigraphy and CMR imaging may yield findings suggestive of chronic myocarditis. Blood cardiac troponin level has not been proven to be useful in diagnosis.
Treatment
Because the etiology of chronic myocarditis is unclear, palliative treatment such as general treatment for heart failure is performed. It has been reported that chronic myocarditis should be treated based on its pathogenesis, such as viral infection or autoimmunity. 31 However, the effectiveness of immunosuppressant has not been confirmed.
Pediatric Myocarditis
Background
Pediatric patients with myocarditis include 30 to 40% with the fulminant type and 40 to 50% with the acute type. Chronic myocarditis is rare in pediatric patients. Among pediatric patients, many have viral infections of types seen in daily life. However, adenovirus and enterovirus infections are common causes of pediatric myocarditis. 32 The prognosis of myocarditis in pediatric patients is similar to that in adult patients. The prognosis of fulminant myocarditis is particularly unfavorable in pediatric patients. 33 
Diagnosis
The typical manifestation of pediatric myocarditis is elevated blood cardiac troponin. Virus can be detected in feces, urine, blood, and sputum. The findings on ECG and echocardiography in pediatric myocarditis are similar to those in adult myocarditis. Echocardiography is the most useful diagnostic tool for pediatric patients. 34 It must be repeated over time, since the disease may progress rapidly over a few hours in pediatric patients. Nuclear medicine techniques with 67 Ga or 99m Tc pyrophosphate and CMR may be helpful in diagnosis. An endomyocardial biopsy is relatively safe for older children.
Treatment
Once myocarditis is suspected, the patient must be transferred to a facility capable of performing pediatric emergency treatment. The primary goal of treatment is to maintain hemodynamics. Respiratory care and cardiopulmonary circulatory support must be concurrently administered. Treatment with antiviral agents or high dose immunoglobulin should be pathogen-specific. 35 
Neonatal Myocarditis
Background
Mothers of neonates with myocarditis often have signs of infection a few days prior to delivery, and affected neonates have signs of heart failure before birth. 36 The risk of horizontal vertical infection from the mother to the neonate is high. Two-thirds of neonates with myocarditis have fulminanttype disease, and the mortality rate is high, at 50% or more. 37 Coxsackie B virus infection, which causes fatal myocarditis, accounts for approximately 75% of cases of neonatal myocarditis. 38 
Diagnosis
Myocarditis occurs in neonates at birth. Initially, patients are presented with cardiopulmonary signs and symptoms without fever. The signs and symptoms may be non-specific, such as not doing well, feeding difficulty, vomiting, dyspnea, and seizures. Detection of elevated cardiac troponin level is useful for diagnosis. Viruses are isolated in approximately 50% of patients.
Treatment
Basically, systemic care and monitoring of the patient is important. Patients must be isolated to prevent spread of infection. Neonates with myocarditis must be immediately transferred to a facility with a neonatal intensive care unit (NICU) or pediatric ICU.
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Cardiac Sarcoidosis
Background
Cardiac sarcoidosis is a systemic granulomatous disease of unknown etiology. The prognosis is closely related to the severity of cardiac manifestations. Attention has been given to Propionibacterium acnes as a cause, since this organism is isolated from tissue affected by sarcoidosis.
Diagnosis
According to the guidelines for cardiac sarcoidosis revised in 2006 ( Table 5) , 39 a myocardial abnormality of unknown cause is occasionally diagnosed as cardiac sarcoidosis after endomyocardial biopsy. If cardiac sarcoidosis is suspected, multidisciplinary collaboration is required for systemic screening for sarcoidosis.
Treatment 40
Corticosteroid treatment is performed for patients with cardiac sarcoidosis, regardless of the severity of cardiac dysfunction. In general, treatment starts at 30 mg/day of prednisolone, and is continued at 5 to 10 mg/day. If arrhythmia or heart failure occurs, the patient should be given standard treatment. Use of a pacemaker, implantable cardioverter defibrillator, drug treatment for heart failure, and cardiac resynchronization therapy should also be considered. Histopathological findings include non-necrotizing epithelioid granuloma in the myocardium, and the patient is found to exhibit histopathological changes in organs other than the heart or by clinical signs.
III Diseases Similar to Myocarditis
(2) Patient group diagnosed based on clinical signs
Histopathological findings do not include non-necrotizing epithelioid granuloma in the myocardium. Patients are diagnosed with cardiac sarcoidosis when they have histopathological changes in organs other than the heart or by clinical signs, together with the following conditions and one or more of six primary diagnostic criteria. 
Diagnosis
Initially, autoimmune myocarditis rarely occurs with myocarditis alone. Pericarditis is associated with the severity of disease activity. A presence of antinuclear antibodies in pericardial effusion, autoantibodies, reduced complement activity, and elevated immune complex levels are supportive of the diagnosis. Echocardiography, myocardial scintigraphy and CMR imaging are used for diagnosis, but an ordinary endomyocardial biopsy is not diagnostic. Scleroderma, systemic lupus erythematosus, polymyositis, dermatomyositis, rheumatoid arthritis, polyarteritis nodosa, and allergic granulomatous angiitis (Churg-Strauss syndrome) are associated with cardiac manifestations. 41 
Treatment
Autoimmune myocarditis is treated with corticosteroids or concurrent use of immunosuppressant if the patient has decreased cardiac function, severe pericardial effusion, or concurrent dysfunction of other organs.
Drug-Induced Myocarditis
Background
This type of myocarditis is induced by drug treatment. Myocarditis may occur in any patient treated with drugs, and must be carefully monitored. Hypersensitivity myocarditis occurs a few days to a few months after exposure to a drug regardless of the dosage used. 42 The severity of toxic myocarditis depends on the dosage and method of administration and drug metabolism in patients, and the onset of this type of myocarditis is slow.
Diagnosis
An endomyocardial biopsy is of crucial importance to the diagnosis of drug-induced myocarditis. However, diagnosis also requires information such as history of drug treatment and clinical conditions after discontinuation of the suspected drug, since differentiation of drug-induced myocarditis from acute myocarditis of other etiologies is difficult. Blood cardiac troponin is useful for diagnosis. Although hypersensitivity myocarditis presents with an elevated eosinophil count, the usefulness of the eosinophil count in diagnosis is unclear.
Treatment
Discontinuation of the suspected drug is the most effective method of treatment. Treatment with corticosteroids is also expected to be useful for hypersensitivity myocarditis and druginduced hypersensitivity syndrome. 43 After the patient recovery, re-administration of the suspected drug must be prevented.
IV Conclusion
The diagnosis of myocarditis is difficult. The first step in diagnosis is to suspect myocarditis. The primary principles of treatment are to make the clinical diagnosis and manage cardiopulmonary emergency promptly. Every effort must be made to confirm the diagnosis of myocarditis by histology, since some cases of specific myocarditis may respond to corticosteroid treatment.
